Demystifying the role of tumor HPV status in recurrent and/or metastatic squamous cell carcinoma of the head and neck

Affiliations

¹ Division of Medical Oncology and Hematology Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
² Division of Medical Oncology and Hematology Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. Electronic address: lillian.siu@uhn.ca.

Free article

Editorial

A Spreafico et al. Ann Oncol. 2014 Apr.

Free article

. 2014 Apr;25(4):760-762.

doi: 10.1093/annonc/mdu095. Epub 2014 Feb 25.

¹ Division of Medical Oncology and Hematology Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
² Division of Medical Oncology and Hematology Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. Electronic address: lillian.siu@uhn.ca.

No abstract available

Comment on

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.
Vermorken JB, Psyrri A, Mesía R, Peyrade F, Beier F, de Blas B, Celik I, Licitra L. Vermorken JB, et al. Ann Oncol. 2014 Apr;25(4):801-807. doi: 10.1093/annonc/mdt574. Epub 2014 Feb 26. Ann Oncol. 2014. PMID: 24577117 Free PMC article.